In March 2020, Hannu Rajaniemi pivoted his biotech company Helix Nanotechnologies’ focus from cancer therapies to Covid-19 vaccines.
The role biotech start-ups can play in a pandemic
Rajaniemi originally co-founded Helix Nanotechnologies in Cambridge, Massachusetts in 2013 to develop cancer therapeutics, which was a personal mission: His mother got sick with and eventually passed due to metastatic breast cancer.
When the company pivoted to working on Covid-19 vaccines, he knew his start-up wouldn’t be one of the first vaccines out of the gate.
“That would have required billions in [Operation] Warp Speed funding,” Rajaniemi says. (HelixNano has received $6.4 million in total funding as of May, according to Crunchbase, from investors including Y Combinator, and has received grant money from Google billionaire Eric Schmidt’s Schmidt Futures.
“In this crisis, the role of a start-up is to pursue more technically challenging, second-generation approaches and find solutions that the less agile bigger players might miss,” he says.
While the first wave of Covid vaccines distributed in the United states from Pfizer/BioNTech, Moderna and Johnson & Johnson have to adapt their vaccines to new strains, HelixNano’s booster vaccine is designed to “provide much broader immunity,” he says.
“The reason we got into this … was that we were worried about mutated SARS-CoV-2 strains able to evade vaccine immunity,” Rajaniemi says. “That is exactly the scenario that is now playing out with the South African, Brazilian and other emerging variants.”
New vaccine technologies: Essentially ‘a zoom function and an amplify function’
Developing a vaccine that is resistant to virus mutations is “an extremely challenging problem technically,” Rajaniemi says.
But with the advantage of being able to build on all the knowledge scientists now have about the virus, HelixNano invented “two completely new vaccine technologies” for which they’ve filed for patents, according to Rajaniemi.
“Essentially, we have a ‘zoom’ function and an ‘amplify’ function for mRNA vaccines,” he says. (Both the Pfizer-BioNTech and Moderna vaccines are mRNA technology, as is Helix Nanotechnologies’ booster.)
“We can make vaccines both more targeted and more powerful than was previously possible,” says Rajaniemi.
The first technology Helix Nanotechnologies developed makes vaccines more accurate.
“Traditional vaccines are blunt instruments. You show the immune system a bit of the virus — like the spike protein that SARS-CoV-2 uses to infect cells — and [the body] generates antibodies against it,” Rajaniemi says. And “those antibodies are essentially random.”
However, HelixNano’s new technology directs antibodies at a very specific part of the virus’ spike protein that “matters the most for preventing infection,” according to Rajaniemi.
“To use a nerdy analogy, imagine the virus is the Death Star [space station from Star Wars]. To blow it up you need to hit a very small target — the thermal exhaust port,” says Rajaniemi (who is also a published science fiction author).
“Your X-Wings [starfighters] could just randomly fire at the whole Death Star, but you would have to get very, very lucky to destroy it,” he says.
“But if you concentrate all your fire on the exhaust port, you have a much better chance — even if your shots get less accurate as the virus mutates.”
The second vaccine technology HelixNano developed is a way to multiply the body’s immune response to a specific vaccine target by a factor of 100.
© Provided by CNBC
Taken together, these two technological advances are what HelixNano has used to build their Covid-19 mutation-resistant booster vaccine.
Beyond its own vaccine technology innovations, HelixNano is also collaborating with Louis Falo’s lab at University of Pittsburgh to make a vaccine technology that can be applied to the skin, rather than by a shot, which therefore can be self-administered.
“The mRNA platform has proven to be effective for vaccination, but does have limitations including the requirement for very low temperatures (cold-chain) across the storage, delivery, and deployment process,” says Falo, who is chairman of the dermatology department at the University of Pittsburgh and a bioengineering professor.
“We imagine an mRNA vaccine that is stable at room temperature and can therefore be readily deployed in global vaccination campaigns the same way that one would distribute and apply Band-Aids.”
(Separately, Falo’s lab has its own skin application vaccine called PittCoVacc, which has submitted preclinical data to the Food and Drug Administration as a Pre-Investigational New Drug Application application.)
Image Credit: CNBC
Post by Amanda Scott, NA CEO. Follow her on twitter @tantriclens
Thanks to Heinz V. Hoenen. Follow him on twitter: @HeinzVHoenen

News
Nasal Vaccines: Stopping the COVID-19 Virus Before It Reaches the Lungs
The Pfizer-BioNTech and Moderna mRNA vaccines have played a large role in preventing deaths and severe infections from COVID-19. But researchers are still in the process of developing alternative approaches to vaccines to improve [...]
NASA Tracking a Huge, Growing Anomaly in Earth’s Magnetic Field – with video
NASA is actively monitoring a strange anomaly in Earth's magnetic field: a giant region of lower magnetic intensity in the skies above the planet, stretching out between South America and southwest Africa. This vast, developing [...]
New, Better Models Show How Infectious Diseases Like COVID-19 Spread
Infectious diseases such as COVID-19 can spread rapidly across the globe. Models that can predict how such diseases spread will strengthen national surveillance systems and improve public health decision-making. The COVID-19 pandemic has emphasized the [...]
Human Antibodies Discovered That Can Block Multiple Coronaviruses Including COVID-19
Results from a Scripps Research and UNC team pave the way for a vaccine and therapeutic antibodies that could be stockpiled to fight future coronavirus pandemics. A team of scientists from Scripps Research and [...]
Nanotechnology could be used to treat lymphedema
The human body is made up of thousands of tiny lymphatic vessels that ferry white blood cells and proteins around the body, like a superhighway of the immune system. It's remarkably efficient, but if [...]
DNA Nanotechnology Tools – From Design to Applications
Suite of DNA nanotechnology devices engineered to overcome specific bottlenecks in the development of new therapies, diagnostics, and understanding of molecular structures. DNA nanostructures with their potential for cell and tissue permeability, biocompatibility, and [...]
Regenerating bone with deer antler stem cells
Scientists from a collection of Chinese research institutions collaborated on a study of organ regeneration in mammals, finding deer antler blastema progenitor cells are a possible source of conserved regeneration cells in higher vertebrates. [...]
AI Takes On Cancer: Analysis of Mutations Could Lead to Improved Therapy
Cancer is a complex and diverse disease, and its range of associated mutations is vast. The combination of these genomic changes in an individual is referred to as their “mutational landscape.” These landscapes vary [...]
Exposing tumours to bacteria converts immune cells to cancer killers
New research on inflammation could lead to better treatments to improve outcomes for people with advanced or previously untreatable cancers. Introducing bacteria to a tumour’s microenvironment creates a state of acute inflammation that triggers [...]
Smart nanotechnology for more accurate delivery of insulin
More efficient and longer lasting glucose-responsive insulin that eliminates the need for people with type 1 diabetes to measure their glucose levels could be a step closer thanks to a Monash University-led project. Published [...]
Efficiently Harvesting Rare Earth Elements From Wastewater Using Exotic Bacteria
The novel strains of cyanobacteria exhibit a fast and efficient “biosorption” of rare earth elements, making recycling possible. Rare earth elements (REEs) are a set of 17 metallic elements that possess similar chemical properties. [...]
Resisting Treatment: Cancer Cells Shrink or Super-Size To Survive
A new approach to image analysis has uncovered how cancer cells manipulate their size as a means of resisting treatment. Researchers have discovered that cancer cells are capable of either shrinking or super-size themselves [...]
New Research Explains Why Children Avoid Severe COVID-19 Symptoms
According to new research, children exhibit a robust initial immune response to the coronavirus, however, they are unable to transfer this response to long-lasting memory T cells like adults do. Researchers led by scientists [...]
Scientists Unravel Protein Map of Mitochondria
A new study sheds light on the organization of proteins within mitochondria. Mitochondria, the “powerhouses” of cells, play a crucial role in the energy production of organisms and are involved in various metabolic and [...]
Mystifying Trapping Phenomenon: A Surprising Way To Catch a Microparticle
New insights could advance microfluidics and drug delivery systems. New study finds obstacles can trap rolling microparticles in fluid Through simulations and experiments, physicists attribute the trapping effect to stagnant pockets of fluid, created [...]
New Alzheimer’s Treatment: Blocking T Cells To Prevent Neurodegeneration
Findings, in mice, open up drug development possibilities for brain diseases linked to tau protein. Nearly two dozen experimental therapies targeting the immune system are in clinical trials for Alzheimer’s disease, a reflection of the growing [...]